Тивлемак

Тивлемак (Apremilast) is an oral medication prescribed to reduce inflammation and manage symptoms in chronic conditions. This non-steroidal, anti-inflammatory drug supports immune response regulation. Suitable for adults seeking long-term symptom control. Always consult a healthcare provider before use.

Тивлемак (Apremilast) is primarily used to treat symptoms associated with chronic inflammatory conditions such as psoriatic arthritis and plaque psoriasis. It helps reduce joint pain, swelling, and skin plaques by modulating the immune system’s response. Patients often use it when other treatments have not provided sufficient relief. It may also be considered for certain types of oral ulcers in adults.

Тивлемак works by inhibiting phosphodiesterase 4 (PDE4), an enzyme involved in the inflammatory process. This helps decrease the production of pro-inflammatory signals in the body. Many users experience a gradual reduction in symptoms over several weeks of consistent use. Common effects include improved mobility and reduced skin discomfort in treated areas.

Keep Тивлемак in a cool, dry place away from direct sunlight and out of reach of children. Do not use if the packaging is damaged or the expiration date has passed. Inform your healthcare provider about any current medications or health conditions before starting treatment. Regular monitoring may be recommended during long-term use.

Тивлемак may interact with certain medications that affect liver enzymes, such as strong CYP450 inducers or inhibitors. Combining it with other immunosuppressants could increase the risk of infections. Alcohol use may worsen side effects like dizziness or nausea. Always discuss your full medication list with a healthcare professional before use.